analysis

Aspira Pathlab & Diagnostics Ltd.

BSE: 540788

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Service Provider

106.90-2.1 (-1.97%)

7 Aug, 12:00 AM

Overview Analysis

Statements Technicals Forecast Peers Resources News

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBox^TMWhat is StyleBox?

Neutral

This stock could not be classified into any of the StyleBoxes and hence a neutral stance.

Detail >

QVM scoreWhat is QVM score?

38.6 / 100

The stock has moderate QVM score relative to other stocks in the market. Neutral.

Analyst ratingWhat is Analyst rating?

No active sell-side coverage. Recommendations not available.

Technical indicatorsSee all >

35 %

Aspira Pathlab & Diagnostics Ltd. on 1D timeframe is bullish for 8 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

	2025 Aug 31	2025 Sept 30	2025 Oct 31	2025 Nov 30	2025 Dec 31	2026 Jan 31	2026 Feb 28	2026 Mar 31	2026 Apr 30	2026 May 31	2026 Jun 30	2026 Jul 31	2026 Aug 08
Multiples
P/E (TTM)	32.73	33.09	30.90	28.53	28.42	27.35	18.09	17.73	20.62	101.69	2,608.36	2,370.60	2,144.88
P/B (latest)	5.44	5.50	5.14	6.64	6.62	6.37	4.07	3.99	4.64	9.70	10.94	9.94	9.00
P/S (TTM)	2.93	2.96	2.76	2.79	2.78	2.67	2.42	2.37	2.76	5.77	5.36	4.87	4.40
CAPE (3Y)	-	-	-	112.91	112.49	108.27	-	-	-	-	-	-	-
CAPE (5Y)	63.41	64.11	59.87	50.96	50.77	48.87	60.28	59.07	68.71	143.71	177.34	161.18	145.83
P/E (1Y Forward)	-	-	-	-	-	-	-	-	-	-	-	-	-
P/S (1Y Forward)	-	-	-	-	-	-	-	-	-	-	-	-	-
Yields (%)
Book to Market	0.18	0.18	0.19	0.15	0.15	0.16	0.25	0.25	0.22	0.10	0.09	0.10	0.11
Earnings yield	3.06%	3.02%	3.24%	3.51%	3.52%	3.66%	5.53%	5.64%	4.85%	0.98%	0.04%	0.04%	0.05%
Operating CF yield	2.79%	2.76%	2.96%	0.46%	0.46%	0.48%	0.38%	0.39%	0.34%	0.16%	1.18%	1.30%	1.44%
FCFE yield	1.30%	1.28%	1.37%	1.25%	1.26%	1.31%	1.46%	1.49%	1.28%	0.61%	0.10%	0.11%	0.12%
FCFF yield	2.62%	2.60%	2.78%	2.54%	2.54%	2.64%	2.95%	3.01%	2.59%	1.25%	0.87%	0.95%	1.05%

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance

NIFTY50

NIFTYHEALTHCARE

Add benchmark

Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary

	ASPIRA	NIFTY50	NIFTYHEALTHCARE

Start Period	04 Jan 2021	04 Jan 2021	04 Jan 2021
End Period	07 Aug 2026	07 Aug 2026	07 Aug 2026
Cumulative Return	299.63%	73.85%	117.14%
CAGR	28.22%	10.43%	14.93%
Volatility (ann.)	60.82%	14.24%	16.14%
Max Drawdown	-78.92%	-17.23%	-20.83%
RoMaD	0.36%	0.61%	0.72%
Sharpe	0.68	0.55	0.77
Sortino	1.1	0.78	1.13
Sortino/√2	0.78	0.55	0.8

Style Analysis

Learn more about stock scores

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score

10.0 / 100

↓

Aspira Pathlab & Diagnostics Ltd. is overvalued relative to other stocks in the market

What is Value score?

Momentum score

87.0 / 100

↑

Aspira Pathlab & Diagnostics Ltd. has high momentum relative to other stocks in the market

What is Momentum score?

Quality score

42.0 / 100

–

Aspira Pathlab & Diagnostics Ltd. has moderate quality relative to other stocks in the market

What is Quality score?

QVM score

38.6 / 100

–

Aspira Pathlab & Diagnostics Ltd. has moderate QVM score with respect to other stocks in the market

What is QVM score?

Scorecard

How to read Scorecard?

A comprehensive scorecard to compare Aspira Pathlab & Diagnostics Ltd. on all metrics with other stocks. Access both rank and scores.

	Value	Market (All Stocks in NSE)	Sector (Healthcare)	Industry Group (Healthcare Services)	Industry (Healthcare Service Provider)
Size and Listing
Days since Listing	3,168.00
Enterprise value	112 Cr
Market Cap	110 Cr
Liquidity
Avg daily turnover 1M	0 Cr
Avg daily volume 1M	12,607
Avg daily turnover 3M	0 Cr
Avg daily volume 3M	9,402
Delivery Percentage	100.00%
Volume surge ratio	1.39
Ownership
DII Holding %	0.00%
QoQ change DII holding %	0.00%
FII Holding %	0.00%
QoQ change FII holding %	0.00%
QoQ change Gov holding %	0.00%
Promoter holding %	46.58%
QoQ change Promoter holding %	28.19%
Promoter pledged %	0.00%
Retail Holding %	53.23%
QoQ change Retail holding %	-28.18%

Checklist

What is Checklist?

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans

Benjamin Graham's Value

Piotroski F-Score

Dreman contrarian value

Peter Lynch Growth/Value

O'Shaugnessy Value

Templeton Growth/Value

Warren Buffet’s Consistent Compounders

John Neff’s contrarian value

Richard Driehaus Momentum Strategy

O'Shaughnessy Tiny Titans

Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

60.0 / 100

Aspira Pathlab & Diagnostics Ltd. passes 3 out of 5 of this checklist's rules

Hits

Market Cap is less than ₹1500 crore

One Year Rel Return is greater than 0%

Stock is in top 25.0 percentile, sorted by Price Momentum score in descending order

Misses

Market Cap is greater than ₹500 crore

PS TTM is less than 1

Frequently Asked Questions

What is the PB ratio of Aspira Pathlab & Diagnostics Ltd.?

The Price-to-Book (PB) ratio of Aspira Pathlab & Diagnostics Ltd. is 9.00. It compares the stock's market price to its book value per share.

What is the EV/EBITDA of Aspira Pathlab & Diagnostics Ltd.?

The EV/EBITDA of Aspira Pathlab & Diagnostics Ltd. is 76.33. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.

What is the debt-to-equity ratio of Aspira Pathlab & Diagnostics Ltd.?

The debt-to-equity (D/E) ratio of Aspira Pathlab & Diagnostics Ltd. is 0.27. The interest coverage ratio stands at -0.19x, reflecting the company's capacity to service its debt from operating earnings. A lower D/E ratio generally indicates a more financially stable company with less leverage.

What is the promoter holding in Aspira Pathlab & Diagnostics Ltd.?

Promoters hold 46.58% of Aspira Pathlab & Diagnostics Ltd. shares as per the latest quarterly shareholding disclosure.

What is the operating profit margin of Aspira Pathlab & Diagnostics Ltd.?

The operating profit margin of Aspira Pathlab & Diagnostics Ltd. is -0.30%, reflecting how much profit the company earns from its core operations relative to revenue.

What is the net profit margin of Aspira Pathlab & Diagnostics Ltd.?

The net profit margin of Aspira Pathlab & Diagnostics Ltd. is 0.21%, indicating the percentage of revenue that remains as profit after all expenses.

What is the Sharpely score for Aspira Pathlab & Diagnostics Ltd.?

On Sharpely's proprietary scoring system, Aspira Pathlab & Diagnostics Ltd. has a Quality Score of 42/100, Value Score of 9.6/100 and Price Momentum Score of 86.7/100, with an overall QVM Score of 38.6/100. The quality rating is moderate, value is low and price momentum is high. Visit the Scorecard and Checklist sections on the Analysis tab for a full breakdown.